Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Mentari Therapeutics (MWG0) Stock Price & Analysis

1 Followers

MWG0 Stock Chart & Stats

€14.30€0.00(0.00%)
At close: 5:30 PM GMT+1
€12€13€14Jul 17Aug 17Oct 16
Day’s Range
EUR 14.30 - EUR 14.30
52-Week Range
EUR 4.70 - EUR 15.80
Previous Close
EUR 14.30
Volume
N/A
Average Volume (3M)
3
Market Cap
EUR 6.00M
Enterprise Value
EUR 6.30M
Total Cash (Recent Filing)
EUR 1.13B
Total Debt (Recent Filing)
EUR 0
Price to Earnings (P/E)
―
Beta
2.95
Next Earnings
Feb 16, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Minimal Reported Debt

Reported total debt is minimal to zero in the most recent periods, reducing interest burden and near-term creditor pressure. This gives the company more flexibility to direct scarce resources toward development and operations, although it does not offset weak capitalization.

2026 Revenue Expansion

The dramatic annual revenue increase in 2026 shows that the business has demonstrated an ability to expand reported sales at scale. If supported by recurring demand, this could improve operating leverage over time, though the pack says the increase was one-time and did not produce profitability.

Focused Therapeutic Platform

A focused research platform around cannabinoids and cannabinoid analogs provides a defined therapeutic and development strategy rather than an unrelated collection of activities. The related subsidiary work also gives the company multiple avenues to advance cannabinoid-based products, subject to successful development.

Bears Say

Persistent Cash Consumption

Sustained negative operating and free cash flow means the company is consuming cash rather than funding its activities internally. Continued heavy burn can restrict investment in development, increase reliance on external financing, and leave less flexibility to manage setbacks over the next several quarters.

Negative Shareholders' Equity

Negative shareholders’ equity signals that accumulated losses have eroded the capitalization base and materially reduced financial flexibility. Even with minimal reported debt, this weak balance-sheet position can constrain funding options and make the company more vulnerable to further losses or capital needs.

Concentrated And Declining Revenue

Declining TTM revenue and reliance on the BayMedica segment create concentration risk in the operating base. Because the other segment remains loss-making, weakness in the principal revenue source could persistently pressure growth, margins, and the company’s ability to reach sustainable profitability.

Mentari Therapeutics News

MWG0 FAQ

What was Mentari Therapeutics’s price range in the past 12 months?
Mentari Therapeutics lowest stock price was €4.70 and its highest was €15.80 in the past 12 months.
What is Mentari Therapeutics’s market cap?
Mentari Therapeutics’s market cap is €6.00M.
When is Mentari Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Mentari Therapeutics’s earnings last quarter?
Mentari Therapeutics released its earnings results on Nov 03, 2026. The company reported -€0.382 earnings per share for the quarter.
Is Mentari Therapeutics overvalued?
According to Wall Street analysts Mentari Therapeutics’s price is currently Undervalued.
Does Mentari Therapeutics pay dividends?
Mentari Therapeutics does not currently pay dividends.
What is Mentari Therapeutics’s EPS estimate?
Mentari Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mentari Therapeutics have?
Mentari Therapeutics has 549,374 shares outstanding.
What happened to Mentari Therapeutics’s price movement after its last earnings report?
Mentari Therapeutics reported an EPS of -€0.382 in its last earnings report. Following the earnings report the stock price went up 5.147%.
Which hedge fund is a major shareholder of Mentari Therapeutics?
Currently, no hedge funds are holding shares in DE:MWG0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology